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ABSTRACT The nucleotide sequences of 27 T-cell recep-
tor P cDNA clones isolated from a human peripheral lympho-
cyte library were determined and compared to five additional
published sequences. These cDNA clones represent 22 distinct
T-cell receptor E-chain variable region (Vp) gene segment
sequences, which fall into 15 different Vp gene subfamilies,
each containing six or fewer members. From this analysis,
we estimate that the repertoire of expressed human Vp genesis <59, apparently much smaller than the immunogiobulin
heavy chain and light chain variable region (VH and VL)
repertoires. Variability plots comparing these human Vp
regions with each other and with published mouse Vp regions
provide evidence for only four hypervariable regions homolo-
gous to those seen in comparisons of immunoglobulin V
regions. Somatic hypermutation appears to be used infrequent-
ly, if at all, in these Vp genes.
T-cell receptors in mammals are capable of responding to a
wide range of foreign antigen determinants and, like their
immunoglobulin counterparts, are enormously diverse. They
are cell-surface heterodimers composed of a and (3 chains
that are divided into variable (V) regions that bind antigen and
major histocompatibility complex (MHC) determinant and
constant (C) regions that are attached to the membrane (1, 2).
Extensive studies in the mouse and in humans suggest that
the Vp region is encoded by three distinct gene segments, V,diversity (D), and joining (J), which rearrange and join to
generate a complete Vp gene in the differentiated T cell (3-7).
Mouse 13-chain genes have at their disposal all of the
diversification mechanisms that are used by immunoglobulin
genes but one. These include germ-line diversity, the main-
tenance of a multiplicity of V, D, and J gene segments,
combinational diversity, the joining of available gene seg-
ments in all possible combinations, and somatic diversifica-
tion (8, 9). Somatic diversification includes junctional diver-
sity, the flexible joining of gene segments at different sites
(10, 11), and N-region diversification, the addition ofrandom
nucleotides at rearranged gene segment junctions (10, 12).
Somatic hypermutation, an increased frequency of nucleo-
tide substitution occurring in and around immunoglobulin V
genes (13, 14), occurs very infrequently, if at all, in T-cell
receptor genes (15-18).
Two features distinguish the diversity patterns in mouse Va
genes from those of their immunoglobulin counterparts.
First, there appear to be only 25-30 highly expressed mouse
Va gene segments (15-17) contrasting with the several hun-
dred to 1000 V gene segments in the V region light chain and
heavy chain (VL and VH) immunoglobulin gene families
(19-21). Second, the published mouse Vp gene segments fallinto 16 V. subfamilies, as defined by nucleic acid hybridiza-
tion with germ-line DNA on Southern blots, of which 13
contain just a single member (15-17, 22). In contrast, the
immunoglobulin VH and VK subfamilies, generally defined as
sets of V gene segments >75% homologous (23), range in size
from 4 to 1000 (9-21).
Conflicting analyses have been presented concerning the
question of the number of hypervariable regions in mouse 13
chains. Hypervariable regions can be defined as sets of
residue positions whose average variability is substantially
greater than the mean variability of the entire sequence.
Immunoglobulin VL and VH regions each have three "clas-
sically" defined hypervariable regions, which fold to consti-
tute the walls of the antigen-binding site (24). Capra and
Kehoe (25) have demonstrated that human VH genes contain
a fourth hypervariable region. Patten et al. (17) have argued
that the Vp regions have substantially more than these fourhypervariable regions (17), perhaps in keeping with the dual
requirement of the T-cell receptor to recognize antigen in the
context of a MHC molecule. In any case, much of the
diversity in the j3 chain seems to be focused at the carboxyl
end of the V region through the heavy use ofjunctional and
N-region diversity, the unique ability to use Do segments in
all three translational reading frames, and the use of a large
family ofJP segments that are, on average, considerably morediverse than JH or JK segments (15-17).
We have analyzed the expression of 13-chain genes in
human peripheral lymphocytes in order to ascertain whether
the strategies for diversification observed in mouse ( chains
are a standard feature ofthe T-cell immune response in higher
vertebrates. We conclude that (i) the strategy of maintaining
a limited repertoire of highly heterogeneous Va gene seg-
ments is shared between mice and humans; (it) there is no
evidence for unique hypervariable regions in Va genes; (ii)
somatic hypermutation of human Vp genes occurs at a very
low frequency, if at all; and (iv) somatic diversification of the
carboxyl end of Vp regions play an important role in the
somatic generation of Vp-region diversity.
MATERIALS AND METHODS
cDNA Library Construction. Human peripheral lympho-
cytes obtained from normal donors were purified on Ficoll
gradients and stimulated for 72 hr with phytohemagglutinin.
Poly(A)+ RNA was isolated by the guanidinium thiocyanate
method (26) followed by one round of selection on oligo(dT)
cellulose. Oligo(dT)-primed cDNA was synthesized by the
method ofHuynh et al. (27). Double-stranded cDNA bearing
EcoRI linkers was fractionated on a 1.2% agarose gel.
Fractions ranging from 1 to 4.5 kilobases (kb) were ligated
into EcoRI-cut XgtlO. The resulting library contained 3.8 x
107 independent recombinant clones.
Abbreviations: kb, kilobase(s); VH, immunoglobulin heavy-chain
variable region; VL, immunoglobulin light-chain variable region; Vp,
Dp, Jp, and Cp, variable, diversity, joining, and constant regions of
the ,3 chain of the T-cell receptor, respectively; MHC, major
histocompatibility complex.
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PL5.2 ITAGCTGGCGTTTCGGGAGCGGATC*GAGTCAACAACCCA120
PL5.61TGCAGGATCTCCTAGCTT6GGGCTGGTGTCTCCTGGGAGCAGGCCCAGTGGATTCTGGAGTCCACA'AACCCCAPLS.1 CAGATCTCCTAGCTT6GGGGCTGGTGTCTCCTGGGAGCAGGCCCAGTGGATTCTGGAGTrCACAC1AACCCCAPL8.4 3TTAGCTAG GATSCTCCTGCTTCGGGGCTGTGTTCTGGG6 AGCAGGCTCCAGGTGGATTCTGTGAGCTCACA CAACCGCPL2.3 GTGTGAGGCCATCACGGAAGATGCTGCTGCTTCTGCTGCTTCTGGGGCCAGCAGGCTCCGGGCTTGGTGCTGTCGTCTCTCAA~CATCCG




1 AAGCACCTGATCACAGCAACTGGACAGCGAGTGACGCTGAGATGCTCCCCTAGGTCTGGAGAC CTCTCTGTGTACTGGTACCAACAGAGCCTGGACCAGGGCCTCCAGTTCCTCATT 24PL5. 1 AAGCACCTGATCACAGCAACTGGACAGCGAGTGACGCTGAGATGICTCCCCTAGGTCTGGAGAC CTCTCTGTGTACTGGTACCAACAGAGCCTGGACCAGGGCCTCCAGTTCCTCATTPL8.14 AAGCACCTGATCACAGCAACTGGACAGCGAGTGACGCTGAGATGCTCCCCTAGGTCTGGAGAC CTCTCTGTGTACTGGTACCAACAGAGCCTGGACCAGGGCCTCCAGTTCCTCATTP12.413 CCTACCGACGAACGGGCCGGTCCCTGTTGAA TTTTTCGTCAAAACTGCAGCTCG CTGATTPMO ACGGTTTGAGGGACTTTGAACATCGTCTGATTAGTCATAGTTGACTATTCGACGGCCT CTGATGPOL8.21 GGTTTT A GACTTTAGTG G CCGGCTCGCAACAG TGA GCGTCGAC CTGATGPL8.21 AGCTGATATCTAGTCAAGGACGGGAGACCTCGTTTTGTCTGATGTGTCCAGGATC TGGACTTCAGGCACAACTATGTTTTGGTATCGACAAGTCCCGAAAGGTC GGGCTACGG CTGATCPL2.14 AGCAGATATCTAGTCAAAGCGTGGAGACTCCCTT6ACTGACAATGTGTCCTCGATATGGCCAATC GAAATGATGTTCTGGTACCGTCAAGCACCGACAGGCGGCCTGACGG CTGATCP15.74 AGCAGGGATATCTGTCAACGTGGAACCTCCCTGACGATCCAGTGTCAAGTCGATAGCCAAGTC ACCATGATGTTCTGGTACCGTCAGCAACCTGGACAGAGCCTGACA CTGATCP14.718 GACT AGCAA CAGTTCGTCCGTCAGCACCTCGGACAGAGCCTTACAGT CTGATTPL7. 16 AGTTTACAAGGGAACATAATACGTCCACCGGA GATTTCGTCCAACAGACCCCAGGACAGGGCCTTCAGTTCCTCTTTPL72.5 AAGG ACAGCAAGTGACACTGAGCTGCTCCCCTATCTCTGGGCAT AGACTGTGTTCCTGGTACCAACAGGCCCCTGGTCAGGGGCCTTCAG TTTCCTCTHPL2.5 AA GTGGAGCTCTAGATGT6ATCCTAATTTCAGGGCAT GACTGCTTGTACTGGTACCGACAAAGCCCTGGGTCAGGGGCCCAGAG TTCTATCHP15. 10GGTAGGGACATTAGCA CG TGAC CCTGGCAGGGGCCCAGAGCTTCTAACTPL514.0 ACGTAGGAGCATAAATTTAAGGAACTTGGA GGCTTAOGAAGGAGCTAGCAGGGGCCAGAGTTTCATGATT
VBYT35 CACCTCATGGAGGTGACAGATGAACAAGAAGTACTTTGAAATGTGAACCAATTCATAGGGCAC AGGCAACTTATTTGGTACAAGACAGAACCTATGAAGCGG ACCGGAGTGCTCATGTTP1Y3.3 CCAGAGGTGACAGAGATGGGACAAGAAGTGACTCTGAGATGTAAACCAATTTCAGGCCAC AACTCCCTTTTCTGGTACAGACAGACCATGATGCGGGGACTGGAGTTGCTCATTP12.6 GGTACAGAGATGGGACAAGACAGTGCTCTGAGATGTGAAACAATTTCAGGGCCAC GACTACTATGTTCTGGTACAGACAGGACTCTAGATGCTTTGCTGGAGATATGTCTTP13.9 AGCTTGCAAGCAGTTGGAACAGAAAGTCAAATTGATTGTGTTCCTAAAATCGGCACAT AGTATATGTATTTGGTATCGAAGAAGGCTCTAAGAAGATTCTCAAGATATGTTTGP13. 1 AGATACTTCTGTTCAAGCAGG ACAGGAAAGCAAGATCTTGGATTTGTTCCTAAAACATGGCACAT AGAAAATGTTACTGGTATCGAAGAAGATCCGGAATGAAGACTACAAC CTCTCP14.12 AGTCTGTTGGCGGAACAGAAGATCACTCTGAGAATGTTCTCAAACCTGAGGCCAT C6CTACATGTACTGGTATCAACAAGATCCAGGAGATGGAACTGACA CTCATCP14.24 AATCAGCTAG GGAACACCAGCTGACTCTCAGATGTGCCCAGGATGAGAACCAC GAATACATGTACTGGTATCGACAAGACCCGGGGCATGGGGCTGAGG CTAATCPL4.34 GCTAGC ACTAAT GG A TTACA A AG CG ATTP18.31 GTCTACCGGCGAAAGTAATATGTTAATTACA ATTTTCGTTGCAACAGCGGTAG ATTATL2I AGGATATCGATCACAAAGACTGGAAAGAAGGTTATCGCTGAACTTTTCTCAGAATATAAGGCAT GAGTAGAATGTCCTGGTATCGACAAGACCCAGGGCTGGGCCTAAGG TTGATCP13.21 AGATGACCAGCGAAAGTAGTGAGTCTAGATCTAAGGGTCAAT GATCGAGATTACCGCGTATCAGTACAAACCCAGATCTGCCTTACGGTTCGATCA
P15.2 241 CAGTATTATAATGGAGAAGAG AGAGCAAAAGGAAACATTCTT GAACGATTCTCCGCACAACAGTTCCCTGACTTGCACTCTGAACTAAACCTGAGCTCTCTGGAGCTG 360
P15.8 CAGTATTATAATGGAGAAGAG AGAGCAAAAGGAAACATTCTT GAACGATTCTCCGCACAACAGTTCCCTGACTTGCACTCTGAACTAAACCTGAGCTCTCTGGAGCTG
PL8. 1 CAGTATTATAATGGAGAAGAG AGAGCAAAAGGAAACATTCTT GAACGATTCTCCGCACAACAGTTCCCTGACTTGCACTCTGAACTAAACCTGAGCTCTCTGGAGCTG




P13. 10 AAGAAAAAGGAGATATTCCT GAGGGGTACAGTGTCTCTAGAGAGAAGAAGGAGCGCTTCTCCCTGATTCTGGAGTCCGCCAGCACC




P14. 18 GAATACTTCAGTGAGACACAG AGAAACAAAGGAAACTTCCCT GGTCGATTCTCAGGGCGCCAGTTCTCTAACTCTCGCTCTGAGATGAATGTGAGCACCTTGGAGCTG
P17. 18 GAATACTTCAGTGAGACACAG AGAAACAAAGGAAACTTCCCT GGTCGATTCTCAGGGCGCCAGTTCTCTAACTCTCGCTCTGAGATGAATGTGAGCACCTTGGAGCTG
P12.5 TTTCAGTATTATGAGGAGGAAGAG AGACAGAGAGGCAACTTCCCT GATCGATTCTCAGGTCACCAGTTCCCTAACTATAGCTCTGAGCTGAATGTGAACGCCTTGTTGCTG
HPBAIL GAAGAGGAAAGC TTCCCT GATCGATTCTCAGCTCGCCAGTTCCCTAACTATAGCTCTGAGCTGAATGTGAACGCCTTGTTGCTG
P14.14 GGGTGCGGCA GATGACTCAGGG CTGCCCAACGATCGGTTCTTTGCAGTCAGGCCTGAGGGATCCGTCTCTACTCTGAAGATCCAGCGCACAGAGCGG
H4P8MIT TACTTCCAAGGCACGGGTGCGGCA GATGACTCAGGG CTGCCCAACGATCGGTTCTTTGCAGTCAGGCCTGAGGGATCCGTCTCTACTCTGAAGATCCAGCGCACAGAGCGG
P15.10 TATTTCCAGAATGAAGCTCAACTA GACAAATCGGGG CTGCCCAGTGATCGCTTCTTTGCAGAAAGGCCTGAGGGATCCGTCTCCACTCTGAAGATCCAGCGCACACAGCAG
P14.9 GTCTACAGCTATGAGAAACTCTCT ATAAATGAAAGT GTGCCA AGTCGCTTCTCACCTGAATGCCCCAACAGCTCTCTCTTAAACCTTCACCTACACGCCCTGCAGCCA
P14.19 GAATTCGCTCC AGTGGCTTCTCACCTGAATGCCCCAACAGCTCTCACTTATTCCTTCACCTACACACCCTGCAGCCA
VBYT35 TACTTTAACAACAACGTTCCGATA GATGATTCAGGG ATGCCCGAGGATCGATTCTCAGCTAAGATGCCTAATGCATCATTCTCCACTCTGAAGATCCAGCCCTCAGAACCC
P13.3 TACTTTAACAACAACGTTCCGATA GATGATTCAGGG ATGCCCGAGGATCGATTCTCAGCTAAGATGCCTAATGCATCATTCTCCACTCTGAAGATCCAGCCCTCAGAACCC
P12.8 AGCTACAATAATAAGGAGCTCATT ATAAATGAAACA GTTCCA AATCGCTTCTCACCTAAATCTCCAGACAAAGCTCACTTAAATCTTCACATCAATTCCCTGGAGCTT
P13.9 GTTTACTTTCAGAATGAAGAACTT ATTCAGAAAGCAGAAATAATCAATGAGCGATTTTTAGCCCAATGCTCCAAAAACTCATCCTGTACCTTGGAGATCCAGTCCACGGAGTCA
PL3. 12 CACTATTCCTATGGAGTTAATTCC ACAGAGAAGGGAGATCTTTCC TCTGAGTCAACAGTCTCCAGAATAAGGACGGAGCATTTTCCCCTGACCCTGGAGTCTGCCAGGCCC
P14.2 CATTACTCATATGGTGTTAAAGAT ACTGACAAAGGAGAAGTCTCA GATGGCTATAGTGTCTCTAGATCAAAGACAGAGGATTTCCTCCTCACTCTGGAGTCGCTACCAGCT
P14.24 CATTACTCAGTTGGTGCTGGTATC ACTGACCAAGGAGAAGTCCCC AATGGCTACAATGTCTCCAGATCAACCACAGAGGATTTCCCGCTCAGGCTGCTGTCGGCTGCTCCC
P15.3 CATTACTCAGTTGGTGAGGGTACA ACTGCCAAAGGAGAGGTCCCT GATGGCTACAATGTCTCCAGATTAAAAAAACAGAATTTCCTGCTGGGGTTGGAGTCGGCTGCTCCC
P18. 1 TACTATTCAATGAATGTTGAGGTG ACTGATAAGGGAGATGTTCCT GAAGGGTACAAAGTCTCTCGAAAAGAGAAGAGGAATTTCCCCCTGATCCTGGAGTCGCCCAGCCCC
ATL21 TATTACTCCTTTGATGTCAAAGAT ATAAACAAAGGAGAGATCTCT GATGGATACAGTGTCTCTCGACAGGCACAGGCTAAATTCTCCCTGTCCCTAGAGTCTGCCATCCCC
P15.2 381 GGGGACTCAGCTTTGTATTTCTGTGCCAGCAGC GTAGGACAATCGATGGG CAATGAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG 480
P15.8 GGGGACTCAGCTTTGTATTTCTGTGCCAGTAGCCG TTATAGAGGGGCGAC CACAGATACGCAGTATTTTGGCCCAGGCACCCGGCTGACAGTG
P18. 1 GGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCG CGGAGGTGGCGTCAATG CCTACAATGAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG
P18.4 GGGGACTCAGCTTTGTATTTCTGTGCCAGCAGC GCTCGGACTAA CACAGATACGCAGTATTTTGGCCCAGGCACCCGGCTGACAGTG
P12. 13 GAAGACAGCAGCTTCTACATCTGCAGTGCTAG TCGCGGTCGCTT CTCCTACAATGAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG
MOLT4 GAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGA GTCGACTAGCGATCCAAAA AATGAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG
P18.21 GAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGA GTCGACTAGCGATCCAAAA AATGAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG
P13. 10 AACCAGACATCTATGTACCTCTGTGCCAGCAGT CCACACCTGGATGG TTCACCCCTCCACTTTGGGAATGGGACCAGGCTCACTGTG
P14.4 AACCAGACATCTATGTACCTCTGTGCCAGCAGT TCCAAAAACAGGGGATGG GAGACCCAGTACTTCGGGCCAGGCACGCGGCTCCTGGTG
P14.22 AACCAGACATCTATGTACCTCTGTGCCAGCAGT CCCTGGAGGGGCTCAG GCAATCAGCCCCAGCATTTTGGTGATGGGACTCGACTCTCCATC
P12. 14 GAAGACAGCAGCATATATCTCTGCAGCGTTGAA GGTGAAGCGGG AGATACGCAGTATTTTGGCCCAGGCACCCGGCTGACAGTG
P15.7 GAAGACAGCAGCATATATCTCTGCAGCGTTGAA CGTTC CACTGAAGCTTTCTTTGGACAAGGCACCAGACTCACAGTT
P14. 18 GGGGACTCGGCCCTTTATCTTTGCGCCAGCAGC ACTAATCAGGGA ACTGAAGCTTTCTTTGGACAAGGCACCAGACTCACAGTT
P17. 18 GGGGACTCGGCCCTTTATCTTTGCGCCAGCAGCTT CGGGGGACAGGGTGGGGGTTTGA CTTTCTTTGGACAAGGCACCAGACTCACAGTT
P12.5 GGGGACTCGGCCCTCTATCTCTGTGCCAGCAGCTT 6 ACCGGGGAGCTGTTTTTTGGAGAAGGCTCTAGGCTGACCGTA
H4PBAIL GGGGACTCGGCCCTGTATCTCTGTGCCAGCAGCT CGCGGAAA ACCCATTACTTCGGGCCAGGCACGCGGCTCCTGGTG
P14. 14 GGGGACTCAGCCGTGTATCTCTGTGCCAGCAGC GTCGGGACAGCC GAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG
HPBMLT GGGGACTCAGCCGTGTATCTCTGTGCCAGCAGC CCAAGGGAGG GAGACCCAGTACTTCGGGCCAGGCACGCGGCTCCTGGTG
P15. 10 GAGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTT GTCCCGGGACAGGCTCGGGTGGG GCAATCAGCCCCAGCATTTTGGTGATGGGACTCGACTCTCCATC
P14.9 GAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAG CCAAGGGTGGCAGGGGGCTAGGGG ACACTGAAGCTTTCTTTGGACAAGGCACCAGACTCACAGTT
P14. 19 GAAGACTCGGCCCTGTATCTCTGCGCCAGCAGCCAAG AATCGAGGGGGCCAACTAGGGGGG CAGATACGCAGTATTTTGGCCCAGGCACCCGGCTGACAGTG
VBYT35 AGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTT CTCGACCTGTTCGG CTAACTATGGCTACACCTTCGGTTCGGGGACCAGGTTAACCGTT
P13.3 AGGGACTCAGCTGTGTACTTCTGTGCCAGCAGT AGCACA AGAGGTGAAAAAATGTTTTTTGGCAGTGGAACCCAGCTCTCTGTC
P12.8 GGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAG CGGGGTCTAG CTCTGGGGCCAACGTCCTGACTTTCGGGGCCGGCAGICAGGCTGACCGTG
P13.9 GGGGACACAGCACTGTATTTCTGTGCCAGCAGCA CCTACCGGACAGGGGG CAATGAGCAGTTCTTCGGGCCAGGGACACGGCTCACCGTG
P13.12 TCACATACCTCTCAGTACCTCTGTGCCAGCATG GGGGTCCC CACCGGGGAGCTGTTTTTTGGAGAAGGCTCTAGGCTGACCGTA
P14.2 CCCGAGACATCTGTGTACTTCTGTGCCACTAGA CCGGGACAGGGGCC AGAGACCCAGTACTTCGGGCCAGGCACGCGGCTCCTGGTG
P14.24 TCCCAGACATCTGTGTACTTCTGTGCCAGCAGT GCCGAAA TGAACACTGAAGCTTTCTTTGGACAAGGCACCAGACTCACAGTT
P15.3 TCCCAAACATCTGTGTACTTCTGTGCCAGCAAA CAGACAGGGTCTTGGGG TCAGCCCCAGCATTTTGGTGATGGGACTCGACTCTCCATC
P18. 1 AACCAGACCTCTCTGTACTTCTGTGCCAGCAGG GGCAGGG GCACAGATACGCAGTATTTTGGCCCAGGCACCCGGCTGACAGTG
ATL21 AACCAGACAGCTCTTTACTTCTGTGCCACCAGTGA CCCAGGACAGAGC AATCAGCCCCAGCATTTTGGTGATGGGACTCGACTCTCCATC
C
PL5.2 481 CT..A...AGGAC....GAAAAA 498
.
CTAGAGGACCTGAAAAACP15.8 CTCGAGGACCTGAAAAACP18. 1 CTAGAGGACCTGAAAAACP18.4 CTAGAGGACCTGAAAAACP182.13 CTAGAGGACCTGAAAAACPL3110 CTAGAGGACCTGAACAAACP18.21 CTCGAGGACCTGAAAAACP13.210 ACAGAGGACCTGAACAAGP14.14 CTCGAGGACCTGAAAAACP14.22 GTAGAGGACCTGAACAAGP12.14 CTAGAGGACCTGAACAAACP15.76 GTAGAGGACCTGAACAAG'P14.5 GTGAGGACCTGAACAAAGHP17. CTCGAGGACCTGAACAAAGP12.54 CTAGAGGACCTGAAAAACH4P8A1T CTCGAGGACCTGAAAAACP14.14 CTAGAGGACCTGAACAAAC
P14.9 GTAGAGGACCTGAACAAG
PL4. 19 CTCGAGGACCTGAAAAAC FIG. 1. Nucleotide sequences ofhuman /3-chain cDNAs. The clones from which nucleotide sequences were
VBYT35 GTAGAGGACCTGAACAAG
P13.3 TTGGAGGACCTGAACAAG determined are indicated at tne left. Clones designated PL were derived from a peripheral lymphocyte cDNA
P12.8 CTGGAGGACCTGAAAAAC 1. OteclnP13.9 CTAGAGGACCTGAAAAAC lirary. Ote lns derived from established human T-cell lines are labeled with the name ofthe cell line exceptPL3.12 CTGGAGGACCTGAAAAAC foVB T5whc isdrvdfo th MO T3cllie(8.CoeA L1(8is eied rma nmc
PL4.2 CTAGAGGACCTGAAAAAC foVB T5whc isdrvdfo th MO T3cl ne28.CoeA L1(8is eiedrmagnmc
PL5:3 CTAGAGGACCTGAACAAG sequence and introns have been edited out in this alignment. Additional germ-line Vi gene segment sequences
PL 1 CTCGAGGACCTGAAAAACATL21 CTA homologous to: L2.13, PL3.9, and PL5.10 have been published, but are not shown here (18). The sequencesP 3."1CTAGAGGACCTGAAAAAC are listed in the order V,91-V1s5, as in Fig. 3.
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Isolation of fl-Chain cDNA Clones. An Ava I/EcoRV C
region fragment of clone pYT35 (28) was used to screen 2 x
10' plaques from the peripheral lymphocyte cDNA library.
Phage DNA was isolated on DEAE columns (29), and cDNA
inserts were sized on 0.7% agarose gels. Inserts >1 kb long
were subcloned into M13 mpl8.
DNA Sequencing. Sequences corresponding to the V, D,
and J regions of the P-chain cDNA clones were determined
by the method of Sanger et al. (30) using 5'-[[a-355]thio]tri-
phosphate (31). Sequencing reactions were primed either
with the 17-base M13 universal sequencing primer, or with an
18-base oligonucleotide, 5' TTCTGATGGCTCAAACAC 3',
which is complementary to a region of perfect homology near
the 5' end of the human Ca1 and Cp2 genes. All sequences
were determined on both strands with the exception ofclones
PL4.9 and PL8.1.
Southern Blot Analyses. VU-specific probes were made by
subcloning restriction fragments from V regions of P-chain
cDNA clones into appropriately digested pUC12 plasmid.
Probes were labeled with [a-32P]dNTPs by nick-translation
(32). Blots were prepared on Zeta-Probe nylon membranes
(Bio-Rad) and hybridized according to the procedures of
Gatti et al. (33) or Reed and Mann (34). Final washes were for
30 min at 650C in lx SSC/0.1% NaDodSO4 (lx SSC is 0.15
M NaCl/0.015 sodium citrate).
RESULTS AND DISCUSSION
Repertoire of Expressed Human Vp Genes. The nucleotide
sequences of 27 ,(3chain cDNA clones derived from a normal
human peripheral blood lymphocyte cDNA library are com-
pared with five published human p-chain cDNA sequences
derived from leukemic cell lines in Fig. 1 (18, 28, 35-37).
There are 22 unique Vp gene segments represented among
these sequences. Six of these Va gene segments appear more
than once in our analysis, and three more have been pub-
lished elsewhere (18). If we assume that these Vp gene
segments represent a random sampling of expressed human
V; gene segments, and that all Vp gene segments are
expressed with essentially the same probability, then a
statistical calculation allows us to estimate the size of the
human expressed Vp gene repertoire (15, 16). This calculation
suggests that the expressed human Vp gene segment pool sizeis <59 at the 95% confidence level. The human Vp gene pool
appears to be intermediate between the estimated sizes of the
mouse Vp repertoire of =25 genes (15-17) and the mouse Va
repertoire of >100 (38) and substantially less than estimated
pool sizes for VH or VK region genes, which contain on the
order of 200-1000 genes (19-21).
Clone PL3.1 does not contain a Vp gene and probably is a
partial copy of a J-C transcript, since its sequence is colinear
with germ-line DNA 5' to its Jp sequence (39). In light of thehigh frequency of multiple (-chain rearrangements in T cells,
it is surprising that apparently none ofthe sequences from our
peripheral blood lymphocyte library is derived from nonpro-
ductive transcripts.
V Gene Subfamilies. The percentage similarity of the
nucjeotide sequences of the 22 different human Vp gene
segments range from 31% to 99%. From this information, we
can divide the characterized human Vp gene segments into 15different subfamilies by the criteria of 75% or more shared
nucleotide homology (23). We have isolated members from 14
of these 15 families. The subfamilies have been designated
Vpl-Vp15, in keeping with the nomenclature proposed by
Barth et al. (15). In this nomenclature, individual members of
subfamilies are identified by a digit following a decimal point.
For example, the V7 subfamily contains at least two mem-
bers, V,97.1 (PL4.9) and V97.2 (PL4.19).
To gain an estimate of the sizes of these human Vp gene
subfamilies, we used Vq gene-specific probes, subcloned
from cDNA clones representing the various subfamilies, to
probe germ-line DNA on genomic blots (Fig. 2). Two differ-
ent restriction digests of human genomic DNA were hybrid-
ized with each probe to establish a correspondence between
numbers of hybridizing bands and numbers of genes. The
method yields only minimum estimates of subfamily sizes.
For example, probes derived from short cDNA clones, such
as Vp6.2, sometimes fail to hybridize to band numbers
commensurate with the known number of subfamily mem-
bers (18). In addition some probes, such as Vp1J, hybridize
to very large genomic DNA fragments, which could contain
multiple Va gene segments. Taking into account both nucle-
otide sequence and Southern blot data, the 15 Vp gene
subfamilies that we have described consist of one subfamily
with six members (Vp6) (18), one with five members (Vp8) (5),
one with four members (Vt13), two with three members (VM5,
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FIG. 2. Southern blot analysis of human germ-line DNA with Vpprobes. HeLa cellDNA was digested with EcoRI (R) andBamH1 (B),
electrophoresed through 1% agarose gels, blotted to nylon mem-
branes, and hybridized with the indicated Vp gene segment probes.
The distance of migration of size standards is indicated. The Vp8 andVN15 subfamilies have been excluded but are published elsewhere (5,
18). The V16 subfamily has been demonstrated to have six members
in a separate analysis (18). Under less stringent washing conditions,
18 additional genes are detected with these probes (data not shown).
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with one member (Vial, V133, V9, V1pO, Vpii, V1J2). There-
fore, human V1t gene subfamilies are more frequently
multimembered than their mouse Vat counterparts.
Variability Among Vpl Gene Segments. Fig. 3 shows an
alignment of 22 unique human Vp3 gene segment amino acid
sequences with 16 mouse Vp sequences. These Vat gene
segments are highly heterogeneous when their amino acid
sequences are compared either within or between species.
The amino acid homology between human Vat genes of
different subfamilies ranges from 14% to 63%. This maximum
range of variability, 86%, is slightly higher than that for
human VH genes at 76%. Despite this variability, there are 16
positions in Vp regions at which one amino acid occurs >75%
of the time. These positions have been indicated in Fig. 3. Six
of these residues are nearly invariant in a comparison of VP,
Va, VL, and VH regions. These positions are those of
structural importance in immunoglobulins such as the
cysteines that form the intrachain disulfide bond in the V
region or residues involved in interchain interactions. Twelve
of the 16 conserved amino acids in Vat gene segments are
conserved at the 75% level in at least one other class of V
region; 10 in Va and VL and eight in VH. Four positions,
Leu-19, His-27, Ser-96, and Ser-97, are conserved exclusive-
ly in Vp regions. This conservation of structurally important
amino acids between Vat Va, VL, and VH is consistent with
the idea that immunoglobulin and T-cell receptor V regions
share similar tertiary structures. Structural predictions for
(3pleated sheets and turns (40, 41) also support the hypoth-
esis of a similarity in three-dimensional structure (data not
shown).
Based on a comparison of translated mouse V1( gene
segment sequences, it has been suggested that V1t gene
segments contain multiple unique hypervariable regions not
observed in comparisons of immunoglobulin V gene seg-
ments (17). The existence of such unique hypervariable
regions in T-cell receptor chains would be particularly
significant in light of the. requirement for T-cell receptor to
recognize not only foreign antigen but also polymorphic
MHC restricting element. Fig. 4 shows a variability plot of
translated V1( gene segment sequences utilizing the algorithm
ofWu and Kabat (24) and analyzing the sequences as aligned






















classically defined hypervariable regions (24) and the third
region as defined by Capra and Kehoe (25). Its peaks of
variability closely match those seen in a variability plot
generated from the sequences of 18 randomly chosen human
VH genes (15). The fourth hypervariable region is located at
the D-J boundary.
Somatic Hypermutation. Comparisons of identical murine
V1( genes used in different cDNA clones (15-17), or compar-
isons of germ-line and rearranged human Vp genes (18),
reveal only a limited number of nucleotide differences, which
may reflect either a low level of somatic hypermutation or
polymorphism. A comparison of identical V1( genes that we
have analyzed confirms this observation. We found no
differences in comparisons of three examples of V133, two
examples of V1(5, two examples of VY6.1, and two examples
of V16.2. We did find a single silent nucleotide substitution in
one of four examples of Va1, a single replacement nucleotide
difference between two examples of V1i4, and a single
replacement nucleotide substitution between two examples
of V1(2.1. The frequency with which these differences occur
is substantially less than that found in comparisons of
immunoglobulin V genes where somatic hypermutation may
create up to 3% sequence difference (13). We believe that
these relatively minor differences reflect genetic polymor-
phisms in the human population, although somatic
hypermutation cannot be excluded as a cause. However,
somatic hypermutation in VL or VH genes usually leads to
multiple substitutions that are concentrated presumably by
selection in the hypervariable regions. The diversity ob-
served here is limited in each case to single nucleotide
changes that are randomly distributed. Furthermore, since
most of the sequences we have examined are derived from
peripheral lymphocytes, we presume that they include ma-
ture T cells, which can be reasonably compared to the mature
B cells in which somatic hypermutation is observed.
Dp and Jp Gene Segment Contributions to Diversity. We
have been able to determine the identity of the Do sequence
(Dill or Dp2) used in 24 of the 31 human D region-containing
cDNA clones we have examined. The 3' end of the Do regions
in individual cDNA clones was determined by reference to
germ-line J(3 and Dp sequences (7, 39). The 3' ends of the V
gene segments were determined by comparison to germ-line
* * * * * * ** * * * ****
I GVTQTPKHLITATGQRVTLRCSPRSGD LSVYWYQQSLDQGLOFLIQYYNGEE RAKGNIL ERFSAQQFPDLHSELNLSSLELGDSALYFCASS
2.1 VVSQHPSWVICKSGTSVKIECRSLDFQATTMFWYRGFPKQSLM LMATSNEGSKATYEQG VEKDKFLINHASLTLSTLTVTSAHPEDSSFYICSA
2.2 VVSQHPSWVICKSGTSVKIECRSLDFQATTMFWYROFPKQSLM LMATSNEGSKATYEOG VEKOKFLINHASLTLSTLTVTSAHPEDSSFYICSAR
3 KVTQSSRYLVKRTGEKVFLECVQDMDH ENMFWYRQDPGLGLR LIYFSYDVKM KEKGDIP EGYSVSREKKERFSLILESASTNQTSMYLCASS
4 VISQKPSRDICQRGTSLTIQCQVDSQV TMMFWYRQQPGQSLT LIATANQGSEATYESG FVIDKFPISRPNLTFSTLTVSNMSPEDSSIYLCSVE
5.1 TPRYLIKTRGQQVTLSCSPISGH RSVSWYQQTPGQGLQFLFEYFSETQ RNKGNFP GRFSGRQFSNSRSEMNVSTLELGDSALYLCASS
5.2 ?QQVTLRCSPKSGH DTVSWYQQALGQGPQ FIFQYYEEEE RQRGNFP DRFSGHQFPNYSSELNVNALLLGDSALYLCASS
5.3 EEES FP DRFSARQFPNYSSELNVNALLLGDSALYLCASS
6.1 WELRCDPISGH TALYWYRQSLGQGPELLIYFQGTGAA DDSG LPNDRFFAVRPEGSVSTLKIQRTERGDSAVYLCASS
6.2 ?QGGPEFLTYFQNEAQL DKSG LPSDRFFAERPEGSVSTLKIQRTQGEDSAVYLCASS
7.1 HLVMGMTNKKSLKCEOHMGH RAMYWYKQKAKKPPELMFVYSYEKLS INES VP SRFSPECPNSSLLNLHLHALQPEDSALYLCASSQ
7.2 ?IRS SGFSPECPNSSHLFLHLHTLQPEDSALYLCASSQ
8.1 GVIQSPRHEVTEMGQEVTLRCKPISGH NSLFWYRQTMMRGLELLIYFNNNVPI DDSG MPEDRFSAKMPNASFSTLKIQPSEPRDSAVYFCASS
8.2 EVTEMGGEVTLRCKPISGH DYLFWYRQTMMRGLELLIYFNNNVPI DDSG MPEDRFSAKMPNASFSTLKIQPSEPRDSAVYFCASS
9 TELGNDKSIKCEQNLGH DTMYWYKGDSKKFLKIMFSYNNKELI INET VP NRFSPKSPDKAHLNLHINSLELGDSAVYFCASS
10 KVTQRPRLLVKASEQKAKMDCVPIKAH SYVYWYRKKLEEELK FLVYFQNEEL IQKAEIINERFLAQCSKNSSCTLEIQSTESGDTALYFCASS
11 DIYQTPRYLVIGTGKKITLECSQTMGH DKMYWYQQDPGMELH LIHYSYGVNS TEKGDLS SESTVSRIRTEHFPLTLESARPSHTSQYLCASM
12 GTPVTLRCHQTENH RYMYWYRQDPGHGLR LIHYSYGVKD TDKGEVS DGYSVSRSKTEDFLLTLESLPAPETSVYFCATR
13.1 GVTQTPKFQVLKTGQSMTLQCAQDMNH EYMSWYRODPGMGLR LIHYSVGAGI TDQGEVP NGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASS
13.2 IHYSVGEGT TAKGEVP DGYNVSRLKKQNFLLGLESAAPSQTSVYFCASK
14 QVTQNPRYLITVTGKKLTVTCSQNMNH EYMSWYRQDPGLGLR QIYYSMNVEV TDKGDVP EGYKVSRKEKRNFPLILESPSPNOTSLYFCASR
15 DVTQTPRNRITKTGKRIMLECSQTKGH DRMYWYRQODPGLGLR LIYYSFDVKD INKGEIS DGYSVSRQAGAKFSLSLESAIPNQTALYFCATS
1 KITQSPRYLILGRANK SLECEQHLGH NAMYWYKQSAEKPPELMFLYNLKOLI RNET VP SRFIPECPDSSKLLLHISAVDPEDSAVYFCASS
2 LLEQNPRWRLVPRGQAVNLRCILKNSQYPWMSWYQQDLQKQLQ WLTLRSPGDK EVKS LPGADYLATRV TDTELRLOVANMSQGRTLYCTCS
3 KVIQTPRYLVKGQGQKAKMRCIPEKGH PVVFWYQQNKNNEFKFLINFQNQEV LOQIDMTEKRFSAECPSNSPCSLEIOSSEAGDSALYLCASS
4 KIIQKPKYLVAVTGSEKILICEQYLGH NAMYWYRQSAKKPLEFMFSYSYQKLM DNOT AS SRFQPQSSKKNHLDLQITALKPDDSATYFCASS
5 GVVQSPRYIIKGKGERSILKCTPISGH LSVAWYQQTQGQELK FFIQHYDKME RDKGNLP SRFSVQQFDDYHSEMNMSALELEDSAVYFCASS
6 IITQTPKFLIGQEGQKLTLKCQQNFNH DTMYWYRQDSGKGLR LIYYSITEND LQKGDLS EGYDASREKKSSFSLTVTSAQKNEMTVFLCASS
7 KVTQMSRYLIKRMGENVLLECGQODMSH ETMYWYRQDPGLGLQ LIYISYDVDS NSEGDIP KGYRVSRKKREHFSLILDSAKTNQTSVYFCA
8. 1 AVTQSPRSKVAVTGGKVTLSCHOTNNH DYMYWYRQDTGHGLR LIHYSYVADS TEKGDIP DGYKASRPSQENFSLILELASLSQTAVYFCASS
8.2 AVTQSPRNKVAVTGGKVTLSCNQTNNH NNMYWYRQDTGHGLR LIHYSYGAGS TEKGDIP DGYKASRPSGENFSLILELATPSQTSVYFCASS
8.3 AVTQSPRNKVTVTGGNVTLSCRQTNSH NYMYWYRQDTGHGLR LIHYSYGAGN LQIGDVP DGYKATRTTGEDFFLLLELASPSGTSLYFCASS
9 TVKGNPRYKLARVGKPVNLICSQTMNH DTMYWYQKKPNQAPK LLLFYYDKIL NREADTF EKFQSSRPNNSFCSLYIGSAGLEYSAMYLCASS
10 SYWYKQHSKKLLKIMFSYNNKQLI VNET VP RRFSPQSSDKAHLNLRIKSVEPEOSAVYLCASS
11 GVIQTPRHKVTGKGQEATLWCEPISGH SAVFWYRGTIVGGLEFLTYFRNQAPI DDSG MPKERFSAGMPNGSHSTLKIQSTGPQOSAVYLCASS
12 FPL MEDGGAFKDRFKAEMLNSSFSTLKIQPTEPKDSAVYLCASS
13 IPLXQLPSDRFSAVRPKGTNSTLKIQSAKQGDTATYLCASS
14 TIHQWPVAEIKAVGSPLSLGCTIKGKSSPNLYWYWGATGGTLQ QLFYSITVGQ VESV VO LHLSASRPKDODQFILSTEKLLLSHSGFYLCAWS
FIG. 3. Amino acid sequences of murine and human Vp genes. Human (h) and murine (m) Va gene-segment nucleotide sequences were
translated and aligned to maximize homology at the amino acid level. Amino acids conserved at the 75% level are indicated by asterisks. VP2.1
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FIG. 4. Variability plot of V gene segments. Variability has been
calculated and plotted for each position in the translated human and
munne Vi gene segments aligned in Fig. 3. Variability is defined as
the number of different amino acids that occur at a particular position
divided by the frequency of the most common amino acid at that
position.
Va and Do sequences when available (18). In other cases, it
was defined as the next nucleotide after the last shared
nucleotide in multiple clones using the same VY gene segment
or Va gene segments of the same subfamily. The D regions
defined by these criteria ranged from 1 to 24 nucleotides long.
At least one clone, PL4.19, appears to contain aD,31.1-D2.1
fusion (L.A.P., unpublished observations).
There are several important contributing factors to diver-
sification at the Vp-Js junction. First, there is extensive use
ofjunctional and N-region diversity, which, in some clones,
nearly obscures the identity of the germ-line Do segment. A
second factor is that independently derived nucleotide se-
quences for the germ-line D,32.1 gene segment vary at one
position (7, 39). We have found cDNA clones that conform
to each of these sequences, indicating that this may be a
common polymorphism in human populations. In all but
three cases, assignment ofDo identity was made based on the
presence of five or more nucleotides colinear with germ-line
D,9 segment sequence.
As would be expected from random usage, Dpl .I rearrang-
es equally to either Jo gene cluster. However, D,81.1 (15/24)is used slightly more often than D1p2.1 (9/24). While this may
reflect the fact that the Dp32.1 sequence contains a stop codonin one of its reading frames, there is no obvious bias against
the use of this blocked reading frame in D 2.1-containing
clones. As in mouse Do gene segment usage (42), we have
observed essentially random usage of both Dogene segments
in all three reading frames. In the case of D1.1, reading
frames 1, 2, and 3 are used 4/15, 6/15, and 5/15 times,
respectively. In D,2.1-containing clones, the first and second
reading frames are used 3/9 and 4/9 times, respectively. The
third reading frame of Dp2.1, which contains the in-frame
termination codon, is used 2/9 times, and in both cases the
termination codon has been deleted in the joining process.
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